Skip to main content
SpringerLink
Log in

Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Patients who develop persistent parkinsonism while on chronic neuroleptic therapy may be predisposed towards the development of tardive dyskinesia (TD). We investigated this issue in an animal model of TD by examining the association between catalepsy and the syndrome of neuroleptic-induced vacuous chewing movements (VCMs). VCMs were measured every 3 weeks for 33 weeks while rats received injections of haloperidol decanoate. Catalepsy was measured after the second through the seventh injections of the depot neuroleptic. There were no correlations between the severity of catalepsy scores after the second or third injections of haloperidol and the severity of the overall VCM syndrome. However, the severity of the catalepsy score following the third through seventh injections of haloperidol strongly correlated with the concurrent number of VCMs. Persistent high catalepsy scores across the six catalepsy rating sessions were strongly associated with the development of persistent severe VCMs. These findings suggest that, to the extent that persistent parkinsonian signs in humans are associated with a propensity towards the development of TD, the VCM syndrome in rats is at least a partially faithful animal model of this relationship.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adams RD, Victor M (1989) Tremor, myoclonus, spasm and tics. In: Principles of neurology, 4th edition. McGraw-Hill, New York, pp 78–79

    Google Scholar 

  • Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366–375

    Google Scholar 

  • Alexander GE, DeLong MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357–381

    Google Scholar 

  • Baronti F, Mouradian MM, Conant KE, Giuffra M, Brughitta G, Chase TN (1992) Partial dopamine agonist therapy of levodopainduced dyskinesias. Neurology 42:1241–1243

    Google Scholar 

  • Bell RCH, Smith RC (1978) Tardive dyskinesia: characterization and prevalence in a state-wide system. J Clin Psychiatry 39:39–47

    Google Scholar 

  • Boyce S, Rupniak NMJ, Steventon MJ, Iversen SD (1990) Differential effects of D1 and D2 agonists in MPTP-treated primates. Neurology 40:927–933

    Google Scholar 

  • Brandon S, McClelland HA, Protheroe C (1971) A study of facial dyskinesia in a mental hospital population. Br J Psychiatry 118:171–184

    Google Scholar 

  • Caligiuri MP, Lohr JB, Bracha HS, Jeste DV (1991) Clinical and instrumental assessment of neuroleptic-induced parkinsonism in patients with tardive dyskinesia. Biol Psychiatry 29:139–148

    Google Scholar 

  • Casey DE (1988) Affective disorders and tardive dyskinesia. L'Encephale 14:221–226

    Google Scholar 

  • Chouinard G, Annable L, Ross-Chouinard A et al. (1979) Factors related to tardive dyskinesia. Am J Psychiatry 136:79–83

    Google Scholar 

  • Crane GE (1972) Pseudoparkinsonism and tardive dyskinesia. Arch Neurol 27:426–430

    Google Scholar 

  • DeLong MR, Crutcher MD, Georgopoulos AP (1985) Primate globus pallidus and subthalamic nucleus: functional organization. J Neurophysiol 53:530–543

    Google Scholar 

  • Egan MF, Karoum F, Wyatt RJ (1995) Effects of acute and chronic clozapine and haloperidol administration on 3-methoxytyramine accumulation in the rat prefrontal cortex, nucleus accumbens, striatum. Eur J Pharmacol 199:191–199

    Google Scholar 

  • Egan MF, Hyde TM, Wyatt RJ, Kleinman JE (1995) Neurolepticinduced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol doses. Psychopharmacology (in press)

  • Fann WE, Davis JM, Janowsky DS (1972) The prevalence of tardive dyskinesia in mental hospital patients. Dis Nerv Syst 33:182–186

    Google Scholar 

  • Gardos G, Cole JO (1983) Tardive dyskinesia and anticholinergic drugs. Am J Psychiatry 140:200–202

    Google Scholar 

  • Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ, Sibley DR (1990) D1 and D2 receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250:1429–1432

    Google Scholar 

  • Gunne LM, Growdon J, Glaeser B (1982) Oral dyskinesia in rats following brain lesions and neuroleptic drug administration. Psychopharmacology 77:134–139

    Google Scholar 

  • Hardie RJ, Lees AJ (1988) Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa. J Neurol Neurosurg Psychiatry 51:850–854

    Google Scholar 

  • Hausner RS (1986) Neuroleptic-induced parkinsonism and Parkinson's disease. J Clin Psychiatry 44:13–16

    Google Scholar 

  • Hietala J, Seppälä T, Lappalainen J, Syvälaht, E (1992) Quantification of SCH 39166, a novel selective D1 dopamine receptor antagonist, in rat brain and blood. Psychopharmacology 106:455–458

    Google Scholar 

  • Hunter R, Ear, CJ, Thornicroft S (1964) An apparently irreversible syndrome of abnormal movements following phenothiazine medication. Proc R Soc Med 57:758–762

    Google Scholar 

  • Jankovic J, Casabona J (1987) Coexistent tardive dyskinesia and parkinsonism. Clin Neuropharmacol 10:511–521

    Google Scholar 

  • Jeste DV, Wyatt RJ (1981) Changing epidemiology of tardive dyskinesia: an overview. Am J Psychiatry 138:297–309

    Google Scholar 

  • Jicha GA, Salamone JD (1991) Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: possible relation to parkinsonian symptoms. J Neurosci 11:3822–3829

    Google Scholar 

  • Jus A, Pineau R, Lachance R et al. (1976) Epidemiology of tardive dyskinesia, part I. Dis Nerv Syst 37:210–214

    Google Scholar 

  • Kane JM, Smith JM (1982) Tardive dyskinesia: prevalence and risk factors, 1959–1979. Arch Gen Psychiatry 39:473–481

    Google Scholar 

  • Kane JM, Woerner M, Leiberman J (1985) Tardive dyskinesia: prevalence, incidence, risk factors. In: Casey DE, Chase TN, Christensen AV et al. (eds) Dyskinesia — research and treatment. Springer, Berlin, pp 72–78

    Google Scholar 

  • Kane JM, Woerner M, Borenstein M (1986) Integrating incidence and prevalence of tardive dyskinesia. Psychopharmacol Bull 22:254–258

    Google Scholar 

  • Kennedy PF, Hershon HI, McGuire RJ (1971) Extrapyramidal disorders after prolonged phenothiazine therapy. Br J Psychiatry 118:509–518

    Google Scholar 

  • Klawans HL, Goetz CG, Perlik S (1980) Tardive dyskinesia, review and update. Am J Psychiatry 137:900–908

    Google Scholar 

  • Klemm WR (1985) Neuroleptic-induced catalepsy: a D2 blockade phenomenon? Pharmacol Biochem Behav 23:911–915

    Google Scholar 

  • Koshikawa N, Beltran KK, Tomiyama K, Kobayashi M, Cools AR (1991) Functional interaction between dopamine D1 and D2 receptors in rat jaw movements. Eur J Pharmacol 201:47–51

    Google Scholar 

  • Künzle H (1975) Bilateral projections from precentral motor cortex to the putamen and other parts of the basal ganglia. Brain Res 88:195–209

    Google Scholar 

  • McCreadie RG, Barron ET, Winslow GS (1982) The Nithsdale schizophrenia survey: II. Abnormal movements. Br J Psychiatry 140:587–590

    Google Scholar 

  • Mouradian MM, Heuser IJE, Baroni F, Fabbrini G, Juncos JL, Chase TN (1989) Pathogenesis of dyskinesias in Parkinson's disease. Ann Neurol 25:523–526

    Google Scholar 

  • Mukherjee S, Rosen AM, Cardenas C, Varia V, Olarte S (1982) Tardive dyskinesia in psychiatric outpatients. Arch Gen Psychiatry 39:466–469

    Google Scholar 

  • Munkvad L, Pakkenberg H, Randrup A (1968) Aminergic systems in the basal ganglia associated with stereotyped hyperactive behaviour and catalepsy. Brain Behav Evo. 1:89–100

    Google Scholar 

  • Murray AM, Waddington JL (1989) The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists. Eur J Pharmacol 160:377–384

    Google Scholar 

  • Ögren SO, Hall H, Köhler C, Magnusson O, Sjöstrand S-E (1986) The selective dopamine D2 antagonist raclopride discriminates between dopamine-mediated behaviomotor functions. Psychopharmacology 90:287–294

    Google Scholar 

  • Ossowska K, Karcz M, Wardas J, Wolfarth S (1990) Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy. Eur J Pharmacol 182:327–334

    Google Scholar 

  • Parashos SA, Marin C, Chase TN (1989) Synergy between a selective D1 antagonist and a selective D2 antagonist in the induction of catalepsy. Neurosci Lett 105:169–173

    Google Scholar 

  • Richardson MA, Craig TJ (1982) The coexistence of parkinsonism-like symptoms and tardive dyskinesia. Am J Psychiatry 139:341–343

    Google Scholar 

  • Rosengarten H, Schweitzer JW, Friedhoff AJ (1986) Selective dopamine D2 receptor reduction enhances a D1 mediated oral dyskinesia in rats. Life Sci 39:29–35

    Google Scholar 

  • Saltz B, Woerner M, Kane J et al. (1991) Prospective study of tardive dyskinesia in the elderly. JAMA 266:2402–2406

    Google Scholar 

  • Sanberg PR (1980) Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors. Nature 284:472–473

    Google Scholar 

  • Smith JM, Baldessarini RJ (1980) Changes in prevalence, severity, recovery in tardive dyskinesias with age. Arch Gen Psychiatry 37:1368–1373

    Google Scholar 

  • Smith JM, Dunn DD (1979) Sex differences in the prevalence of severe tardive dyskinesia. Am J Psychiatry 136:1080–1082

    Google Scholar 

  • Steinpreis RE, Baskin P, Salamone JD (1993) Vacuous jaw movements induced by sub-chronic administration of haloperidol: interactions with scopolamine. Psychopharmacology 111:99–105

    Google Scholar 

  • Stoessl AJ, Dourish CT, Iversen SD (1989) Chronic neuroleptic-induced mouth movements in the rat: suppression by CCK and selective dopamine D1 and D2 receptor antagonists. Psychopharmacology 98:372–379

    Google Scholar 

  • Tomer R, Mintz M, Kempler S, Sigal M (1987) Lateralized neuroleptic-induced side-effects are associated with asymmetric visual-evoked potentials. Psychiatry Res 22:311–318

    Google Scholar 

  • Waddington JL (1990) Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology 101:431–447

    Google Scholar 

  • Wolf ME, Ryan JJ, Mosnaim AD (1982) Organicity and tardive dyskinesia. Psychosomatics 23:475–480

    Google Scholar 

  • Wolf ME, Chevesich J, Lehre, E, Mosnaim AD (1983) The clinical association of tardive dyskinesia and drug-induced parkinsonism. Biol Psychiatry 18:1181–1188

    Google Scholar 

  • Yassa R, Nair V, Schwartz G (1984) Tardive dyskinesia: a two-year follow-up study. Psychosomatics 25:852–855

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Brain Disorders Branch, Intramural Research Program, National Institute of Mental Health, St. Elizabeths Hospital, 2700 Martin Luther King Avenue, S.E., 20032, Washington, DC, USA

    T. M. Hyde, D. R. Weinberger & J. E. Kleinman

  2. Neuropsychiatry Branch, Intramural Research Program, National Institute of Mental Health, St. Elizabeths Hospital, 2700 Martin Luther King Avenue, S.E., 20032, Washington, DC, USA

    M. F. Egan, L. L. Wing & R. J. Wyatt

Authors
  1. T. M. Hyde
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. R. Weinberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. E. Kleinman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. F. Egan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. L. Wing
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. J. Wyatt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hyde, T.M., Weinberger, D.R., Kleinman, J.E. et al. Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate. Psychopharmacology 118, 142–149 (1995). https://doi.org/10.1007/BF02245832

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02245832

Key words

Search

Navigation